EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning

Gamalat A Elgedawy, Mohamed Samir, Naglaa S Elabd iD, Hala H Elsaid, Mohamed Enar, Radwa H Salem, Belal A Montaser, Hind S AboShabaan, Randa M Seddik, Shimaa M El-Askaeri iD, Marwa M Omar, Marwa L Helal

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0302977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Gamalat A Elgedawy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt. Hauptthemen laut MEDLINE: COVID-19, Machine Learning, Biomarkers, Metabolomics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

After its emergence in China, the coronavirus SARS-CoV-2 has swept the world, leading to global health crises with millions of deaths. COVID-19 clinical manifestations differ in severity, ranging from mild symptoms to severe disease. Although perturbation of metabolism has been reported as a part of the host response to COVID-19 infection, scarce data exist that describe stage-specific changes in host metabolites during the infection and how this could stratify patients based on severity.

Methods

Given this knowledge gap, we performed targeted metabolomics profiling and then used machine learning models and biostatistics to characterize the alteration patterns of 50 metabolites and 17 blood parameters measured in a cohort of 295 human subjects. They were categorized into healthy controls, non-severe, severe and critical groups with their outcomes. Subject’s demographic and clinical data were also used in the analyses to provide more robust predictive models.

Results

The non-severe and severe COVID-19 patients experienced the strongest changes in metabolite repertoire, whereas less intense changes occur during the critical phase. Panels of 15, 14, 2 and 2 key metabolites were identified as predictors for non-severe, severe, critical and dead patients, respectively. Specifically, arginine and malonyl methylmalonyl succinylcarnitine were significant biomarkers for the onset of COVID-19 infection and tauroursodeoxycholic acid were potential biomarkers for disease progression. Measuring blood parameters enhanced the predictive power of metabolic signatures during critical illness.

Conclusions

Metabolomic signatures are distinctive for each stage of COVID-19 infection. This has great translation potential as it opens new therapeutic and diagnostic prospective based on key metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Machine LearningBiomarkersMetabolomicsSeverity of Illness IndexHumansMaleFemaleMiddle AgedAdultSARS-CoV-2AgedMetabolome

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
  • Faculty of Veterinary Medicine, Department of Zoonoses, Zagazig University, Zagazig, Egypt.
  • Faculty of Medicine, Department of Tropical Medicine, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
  • Al Mahala Elkobra Fever Hospital, Al Mahala Elkobra, Egypt.
  • Department of Clinical Microbiology and Immunology, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
  • Faculty of Medicine, Department of Clinical Pathology, Menoufia University, Shebin El-Kom, Menoufia, Egypt.

ORCID-Profile: Naglaa S Elabd, Shimaa M El-Askaeri

Förderung

  • Science and Technology Development Fund

Zitieren

APA

Elgedawy, G. A., Samir, M., Elabd, N. S., Elsaid, H. H., Enar, M., Salem, R. H., Montaser, B. A., AboShabaan, H. S., Seddik, R. M., El-Askaeri, S. M., Omar, M. M., & Helal, M. L. (2024). Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning. PLOS ONE. https://doi.org/10.1371/journal.pone.0302977

Vancouver

Elgedawy GA, Samir M, Elabd NS, Elsaid HH, Enar M, Salem RH, et al. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning. PLOS ONE. 2024. doi:10.1371/journal.pone.0302977

BibTeX
@article{Elgedawy2024,
  author = {Elgedawy, Gamalat A and Samir, Mohamed and Elabd, Naglaa S and Elsaid, Hala H and Enar, Mohamed and Salem, Radwa H and Montaser, Belal A and AboShabaan, Hind S and Seddik, Randa M and El-Askaeri, Shimaa M and Omar, Marwa M and Helal, Marwa L},
  title = {Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0302977}
}
Kostenlos starten →